Replies to post #431 on CVS Health Corporation (CVS)

[FUNMAN]

CVS Health announces availability of Pfizer-BioNTech COVID-19 pediatric vaccine to children ages five to 11

A young person, seen inside a CVS Pharmacy, receives a COVID-19 vaccination.

Wednesday, November 3, 2021

Shots for eligible children to be available at nearly 1,700 CVS Pharmacy locations

WOONSOCKET, R.I. — CVS Health (NYSE: CVS) today announced that select CVS Pharmacy locations will be offering a two-dose primary series of the Pfizer-BioNTech COVID-19 pediatric vaccine to children ages five to 11 years of age starting on Sunday, 11/7, upon receipt and confirmation of vaccine supply. This follows authorization of the vaccine by the Centers for Disease Control and Prevention (CDC) based on guidance from the organization's Advisory Committee on Immunization Practices and Food and Drug Administration (FDA) Emergency Use Authorization. Parental or legal guardian consent is required for this age group, and children must be accompanied by an adult.

"We know many parents have been waiting for the opportunity to vaccinate their young children and are looking for convenient access to a trusted resource for vaccinations," said Troyen A. Brennan, M.D., MPH, Executive Vice President and Chief Medical Officer of CVS Health. "Our immunizers have been preparing for this important role, and stand ready to help answer parents' questions, guide them and their children through the process, and administer the vaccines safely, with kindness and caring."

The Pfizer-BioNTech pediatric vaccine is one-third of the adult dose and will be available at nearly 1,700 CVS Pharmacy locations in 46 states, Puerto Rico and Washington D.C. Because the Pfizer-BioNTech vaccine is the only FDA-authorized COVID-19 vaccine for children in this age group, patients are strongly encouraged to schedule an appointment online at CVS.com or through the CVS App to ensure availability. The scheduling tool will only display appointments at CVS Pharmacy locations that have the Pfizer-BioNTech pediatric vaccine once the patient's age is provided.

CVS Health has administered approximately 43 million COVID-19 vaccines to date and has been administering the COVID-19 vaccine to children ages 12 years and older since authorized by the FDA and recommended for that age group by the CDC earlier this year. In addition, CVS Pharmacy has comprehensive experience in safely providing many other vaccines to children, such as seasonal flu, Tdap and chickenpox. Parents must accompany children ages five to 15 years of age, and CVS Pharmacy recommends that children wear clothing that allows easy access to their arms, such as a short sleeve shirt. As with the adult COVID-19 vaccination, children and their parent or guardian will need to remain in the pharmacy area for at least 15 minutes following vaccination for observation.

CVS Pharmacy locations that will be administering the vaccine to children ages five to 11 years were selected because these locations have vaccinators on site who are solely focused on administering vaccines. CVS vaccinators in these locations have also received additional training on managing pediatric vaccinations to help ensure the best experience for children and their families. In addition, CVS Health is developing an in-store experience focused on reassuring and supporting the child and their parent or guardian throughout the process. This includes the introduction of various child-friendly elements in the coming weeks designed to help motivate and reward the children and help keep them entertained during the post-vaccination observation period.

CVS Health has played a prominent role in administering third doses to immunocompromised patients and booster shots to eligible populations, while continuing to focus on removing the barriers that make it difficult for certain populations to easily access the COVID-19 vaccine. In addition, the company has administered approximately 38 million COVID-19 tests across the country to date.

Multimedia assets, including sound bites from Stephanie Whyte, MD, a trained pediatrician and Senior Clinical Solutions Medical Director for CVS Health, and b-roll and still photography from in-store pediatric COVID-19 vaccinations, are available here.

About CVS Health
CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and our nearly 300,000 dedicated colleagues including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health whether that's managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system and their personal health care by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Learn more at www.cvshealth.com.

Media contact
Matthew Blanchette
401-524-6185
[e-mail]

[FUNMAN]

Your headline missed. Yesterday was a historic PPS gain.

DiscoverGold Member Level Wednesday, 11/03/21 08:48:19 AM
Re: None 0
Post #
431
of 433
CVS Health (CVS) Stock Slips On Q3 Earnings Beat, 2021 Profit Outlook Boost
By: TheStreet | November 3, 2021

• CVS lifted its full-year profit outlook following stronger-than-expected third quarter earnings that included $73.8 billion in total group revenues.

CVS Health Corp. (CVS) posted stronger-than-expected third quarter earnings Wednesday, and lifted its 2021 profit forecast, as COVID vaccinations powered solid gains in retail and pharmacy sales.

CVS said adjusted earnings for the three months ending in September were pegged at $1.97 per share, up 18.7% from the same period last year and firmly ahead of the Street consensus forecast of $1.78 per share. Group revenues, CVS said, rose 10% from last year to $73.8 billion, again topping analysts' estimates of a $70.5 billion tally.

Same sore sales were up 9.6% from last year, CVS said, while pharmacy store sales rose 8.8%, both benefiting from the group's administering of 11 million COVID vaccinations and a further 8 million tests over the three month period.

Looking into the final months of the 2021 financial year, CVS lifted its forecast for adjusted earnings, which it now sees in the region of $7.90 to $8.00 per share, a 20 cents per share improvement from its prior forecast, with cash flow from operations in the region of $13 billion to $13.5 billion.

"We outperformed expectations once again and continue to lead the way in changing how, when and where care is delivered for millions of Americans," said CEO Karen Lynch. "Our services are responsive to evolving consumer needs, from administering millions of COVID-19 tests and vaccines to offering primary care accessible from virtually anywhere, and our touchpoints allow for unmatched impact."

CVS shares were marked 0.7% lower in pre-market trading immediately following the earnings release to indicate an opening bell price of $90.50 each.

Pharmacy Services revenues rose 9.4% to $39.05 billion, CVS said, Retail sales rose 10% to $25 billion, "primarily driven by the administration of COVID-19 vaccinations and diagnostic testing, increased prescription and front store volume."

The group's healthcare benefits division saw sales rise 9.5% to $20.5 billion as it added Aetna's operations to its legacy business.

Read Full Story »»»

DiscoverGold